Synthetic Fab fragments that bind the HIV-1 gp41 heptad repeat regions

Biochemical and Biophysical Research Communications

Volumn 413, Issue 4, 2011, Pages 611-615

  Liu, Yanyun ^a   Regula, Lauren K ^a   Stewart, Alex ^a   Lai, Jonathan R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody engineering; HIV 1; Phage display

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN F(AB) FRAGMENT; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SYNTHETIC IMMUNOGLOBULIN F(AB) FRAGMENT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY ENGINEERING; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS ENTRY;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PROTEIN STRUCTURE, SECONDARY; REPETITIVE SEQUENCES, NUCLEIC ACID; SERINE; TYROSINE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80053596391     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.012     Document Type: Article

References (28)

1. Harrison S.C. Viral membrane fusion. Nat. Struct. Mol. Biol. 2008, 15:690-698.
2. Eckert D.M., Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 2001, 70:777-810.
3. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659.
4. Chen B., Vogan E.M., Gong H., Skehel J.J., Wiley D.C., Harrison S.C. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005, 433:834-841.
5. Chan D.C., Fass D., Berger J.M., Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997, 89:263-273.
6. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997, 387:426-430.
7. Kilby J.M., Hopkins S., Venetta T.M., DiMassimo B., Cloud G.A., Lee J.Y., Alldredge L., Hunter E., Lambert D., Bolognesi D., Matthews T., Johnson M.R., Nowak M.A., Shaw G.M., Saag M.S. Potent suppression of HIV-1 replication in humans by T-20 a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 1998, 4:1302-1307.
8. Root M.J., Kay M.S., Kim P.S. Protein design of an HIV-1 entry inhibitor. Science 2001, 291:884-888.
9. Luftig M.A., Mattu M., Di Giovine P., Geleziunas R., Hrin R., Barbato G., Bianchi E., Miller M.D., Pessi A., Carfí A. Structural basis for HIV-1 neutralization by a pg41 fusion intermediate-directed antibody. Nat. Struct. Mol. Biol. 2006, 13:740-747.
10. Sabin C., Corti D., Buzon V., Seaman M.S., Lutje Hulsik D., Hinz A., Vanzetta F., Agatic G., Silacci C., Mainetti L., Scarlatti G., Sallusto F., Weiss R., Lanzavecchia A., Weissenhorn W. Crystal structure size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. PLoS Pathog. 2010, 18:e101195.
11. Gustchina E., Li M., Louis J.M., Anderson D.E., Lloyd J., Frisch C., Bewley C.A., Gustchina A., Wlodawer A., Clore G.M. Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41. PLoS Pathog. 2010, 6:e1001182.
12. Koide S., Sidhu S.S. The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins. ACS Chem. Biol. 2009, 15:325-334.
13. Fellouse F.A., Sidhu S.S. Synthetic therapeutic antibodies. Nat. Chem. Biol. 2006, 2:682-688.
14. Bostrom J., Yu S.F., Kan D., Appleton B.A., Lee C.V., Billeci K., Man W., Peale F., Ross S., Wiesmann C., Fuh G. Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site. Science 2009, 323:1610-1614.
15. Rizk S.S., Paduch M., Heithaus J.H., Duguid E.M., Sandstrom A., Kossiakoff A.A. Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteins. Nat. Struct. Mol. Biol. 2011, 18:437-442.
16. Cobaugh C.W., Almagro J.C., Pogson M., Iverson B., Georgiou G. Synthetic antibody libraries focused towards peptide ligands. J. Mol. Biol. 2008, 378:4 622-633.
17. Birtalan S., Fisher R.D., Sidhu S.S. The functional capacity of the natural amino acids for molecular recognition. Mol. BioSyst. 2010, 6:1186-1194.
18. Fellouse F.A., Li B., Compaan D.M., Peden A.A., Hymowitz S.G., Sidhu S.S. Molecular recognition by a binary code. J. Mol. Biol. 2005, 348:1153-1162.
19. Koide A., Gilbreth R.N., Esaki K., Tereshko V., Koide S. High-affinity single-domain binding proteins with a binary-code interface. Proc. Natl. Acad. Sci. USA 2007, 104:6632-6637.
20. Frey G., Rits-Volloch S., Zhang X.Q., Schooley R.T., Chen B., Harrison S.C. Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Proc. Natl. Acad. Sci. USA. 2006, 103:13938-13943.
21. Da Silva G.F., Harrison J.S., Lai J.R. Contribution of light chain residues to high affinity binding in an HIV-1 antibody explored by combinatorial scanning mutagenesis. Biochemistry 2010, 49:5464-6472.
22. Lee C.V., Sidhu S.S., Fuh G. Bivalent antibody phage display mimics natural immunoglobulin. J. Immunol. Methods. 2004, 284:119-132.
23. Fellouse F.A., Wiesmann C., Sidhu S.S. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc. Natl. Acad. Sci. USA 2004, 101:12467-12472.
24. DeLano W.L., Cunningham B.C. " Rapid Screening of Phage Displayed Protein Binding Affinities by Phage ELISA" in Phage Display: A Practical Approach 2004, 85-94. Oxford University Press, New York, NY. T. Clackson, H.B. Lowman (Eds.).
25. Fellouse F.A., Esaki K., Birtalan S., Raptis D., Cancasci V.J., Koide A., Jhurani P., Vasser M., Wiesmann C., Kossiakoff A.A., Koide S., Sidhu S.S. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J. Mol. Biol. 2007, 373:924-940.
26. Birtalan S., Zhang Y., Fellouse F.A., Shao L., Schaefer G., Sidhu S.S. The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J. Mol. Biol. 2008, 377:1518-1528.
27. Liu S., Boyer-Chatenet L., Lu H., Jiang S. Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41. J. Biomol. Screen. 2003, 8:685-693.
28. Frey G., Chen J., Rits-Volloch S., Freeman M.M., Zolla-Pazner S., Chen B. Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies. Nat. Struct. Mol. Biol. 2010, 17:1486-1491.